HIV can rebound in your body within days of stopping medication. Viral load becomes detectable as early as 3 to 6 days after the last dose of oral antiretroviral therapy, and it typically climbs rapidly in the weeks that follow. There is no safe window for skipping HIV medication without medical supervision.
What Happens in the First Days and Weeks
HIV never fully leaves your body, even when treatment keeps it undetectable. The virus hides inside long-lived immune cells in what’s called the latent reservoir. These infected cells sit quietly while you’re on medication, but when drug levels drop, the virus reactivates. Normal immune signaling is enough to wake it up: when those cells get triggered by everyday immune responses, the hidden virus starts copying itself again.
This rebound is fast. Viral load can be measurable within 3 to 6 days of stopping pills, and within a few weeks it often returns to pre-treatment levels. Once the virus is circulating again, you can transmit HIV to partners, and the protective benefit of “undetectable equals untransmittable” no longer applies.
How Your Immune System Responds
Your CD4 cells, the immune cells HIV targets, begin declining as soon as the virus rebounds. In one study tracking people who fell out of care for a median of about 2.7 months, CD4 counts dropped from 297 to 248 cells per microliter. That’s a meaningful loss in a short period, and the decline tends to accelerate the longer you’ve been on treatment before stopping. People with higher CD4 counts at the time they stop often experience steeper drops, likely because the virus has more targets to infect.
This matters because CD4 count is the main measure of how well your immune system can fight infections. A count below 200 is the threshold for an AIDS diagnosis, and every step closer to that line increases your vulnerability to infections your body would normally handle easily.
Serious Health Risks Beyond Immune Decline
The consequences of stopping treatment go well beyond a rising viral load. The landmark SMART trial, published in the New England Journal of Medicine, compared people who stayed on continuous therapy to people who took planned breaks. The results were so striking that the trial was stopped early. People in the treatment interruption group were 2.6 times more likely to develop an opportunistic infection or die from any cause. Their risk of death alone was 1.8 times higher, and their risk of major cardiovascular, kidney, or liver disease was 1.7 times higher.
That cardiovascular risk isn’t a coincidence. When HIV replicates freely, it drives chronic inflammation throughout the body. Markers like C-reactive protein, D-dimers, and interleukin-6 rise in the blood, all of which are linked to heart disease and blood clots. People living with HIV already face a cardiovascular risk roughly 1.5 to 2 times higher than HIV-negative people, and uncontrolled viral replication makes that worse.
The Drug Resistance Problem
Stopping and restarting medication creates one of the most dangerous long-term risks: drug resistance. When the virus replicates in the presence of fluctuating drug levels (during the days your body is clearing the medication), it has the opportunity to develop mutations that make your current regimen less effective. This is particularly risky if you stop abruptly without medical guidance, because different drugs in your combination clear your body at different rates. For a period of days, you may have partial drug levels, which is the perfect environment for resistance to develop.
Interestingly, in people who already have extensive drug resistance, a treatment interruption can cause the resistant virus to be replaced by “wild-type” virus (the non-resistant form) within about four months. This happens in roughly 64% of cases. But this doesn’t mean interruptions are beneficial. It simply means the resistant strains are still lurking and will reemerge once drugs are reintroduced, potentially leaving you with fewer treatment options going forward.
What About Long-Acting Injectables?
If you’re on monthly injections rather than daily pills, the timing rules are different but still strict. The FDA labeling for the monthly injectable regimen allows a window of 7 days before or after your scheduled appointment. If you’ll miss by more than 7 days, you’re supposed to bridge the gap with daily oral pills for up to two consecutive missed injection visits. If you miss an injection by more than 7 days and haven’t taken oral pills in the meantime, your provider needs to reassess whether resuming injections is appropriate, because the risk of resistance is real. An alternative fully suppressive regimen should begin no later than one month after the last injection.
How Long It Takes to Get Back on Track
Restarting treatment works, but getting back to undetectable isn’t instant. For people restarting on a second-line regimen (which is common if resistance has developed), the median time to achieve viral suppression again is about 10 months. If you’re restarting the same regimen that worked before and no resistance has developed, the timeline can be shorter, but it still takes weeks to months. During that entire period, the virus is active, your immune system is under stress, and you can transmit HIV to others.
The speed of re-suppression depends on several factors: how long you were off treatment, whether resistance mutations developed, your CD4 count when you restart, and how consistently you take the medication once you begin again. People who restart quickly after a short gap generally do better than those who stay off treatment for months or years.
Why People Stop and What Helps
Nobody stops HIV medication because they want worse health outcomes. The real reasons are practical: side effects, cost, insurance gaps, mental health struggles, stigma, housing instability, or simply the fatigue of taking pills every day for life. If you’re considering stopping or have already missed doses, the most important thing is to talk to your care team honestly. They can often switch you to a regimen with fewer side effects, connect you with assistance programs, or help you plan around life disruptions.
If you’ve been off medication for any length of time, restarting sooner is always better than waiting. Your provider will likely check your viral load and CD4 count, test for resistance mutations, and choose a regimen based on what’s most likely to work. The immune damage from a treatment gap is real, but most people can still achieve viral suppression again with the right approach.